TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataEC50: 530nMAssay Description:Inhibition of 8Fluo-cAMP binding to recombinant human His-tagged EPAC1 (157 to 881 residues) expressed in Escherichia coli measured after 5 mins by f...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataEC50: 1.09E+3nMAssay Description:Inhibition of 8Fluo-cAMP binding to recombinant human His-tagged EPAC1 (157 to 881 residues) expressed in Escherichia coli measured after 5 mins by f...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataEC50: 2.20E+3nMAssay Description:Activation of EPAC1 DEP1 deletion mutant (unknown origin) expressed in mouse NIH-3T3-A14 cells assessed as increase in Rap1b- fluorescent nucleotide ...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataEC50: 2.54E+3nMAssay Description:Inhibition of 8Fluo-cAMP binding to recombinant human His-tagged EPAC1 (157 to 881 residues) expressed in Escherichia coli measured after 5 mins by f...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataEC50: 2.75E+3nMAssay Description:Inhibition of 8Fluo-cAMP binding to recombinant human His-tagged EPAC1 (157 to 881 residues) expressed in Escherichia coli measured after 5 mins by f...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataEC50: 5.00E+3nMAssay Description:Activation of recombinant EPAC1 (149 to 881 residues) (unknown origin) assessed as stimulation of dissociation of fluorescent MANT-GDP from recombina...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataEC50: 5.00E+3nMAssay Description:Activation of recombinant EPAC1 (149 to 881 residues) (unknown origin) assessed as stimulation of dissociation of fluorescent MANT-GDP from recombina...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataEC50: 5.00E+3nMAssay Description:Activation of recombinant EPAC1 (149 to 881 residues) (unknown origin) assessed as stimulation of dissociation of fluorescent MANT-GDP from recombina...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataEC50: 5.62E+3nMAssay Description:Inhibition of 8Fluo-cAMP binding to recombinant human His-tagged EPAC1 (157 to 881 residues) expressed in Escherichia coli measured after 5 mins by f...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 3.20E+3nMAssay Description:Inhibition of EPAC1 (unknown origin) assessed as cAMP-mediated GEF activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.08E+4nMAssay Description:Antagonist activity at EPAC1 (unknown origin) assessed as cAMP-induced guanine nucleotide exchange factor activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.08E+4nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 2.40E+3nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 5.70E+3nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 5.70E+3nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.16E+4nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 7.80E+3nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 9.70E+3nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 4.30E+3nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 2.40E+3nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 8.90E+3nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 2.60E+3nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 4.10E+3nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 4.00E+3nMAssay Description:Antagonist activity at human recombinant EPAC1 assessed as inhibition of Rap1b-bGDP exchange activityMore data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.08E+4nMAssay Description:Inhibition of recombinant C-terminal FLAG/HA-tagged EPAC1 (unknown origin) expressed in retrovirus infected human HeLaS3 cells assessed as reduction ...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.02E+4nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 3.86E+4nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 7.20E+3nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 2.40E+3nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: >1.50E+5nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.19E+4nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 9.00E+3nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.02E+4nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 8.60E+3nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.08E+4nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 6.70E+3nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 8.50E+3nMAssay Description:In vito concentration required to displace [3H]-BRM (Kd = 1.0 nM and concentration is 1.8 nM) from opioid receptor kappa 2 in guinea brain membranes.More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 2.70E+3nMAssay Description:In vito concentration required to displace [3H]cyclofoxy (Kd = 0.8 nM and concentration is 1.3 nM) from mu and kappa2 receptor in rat brain membranes...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 3.00E+3nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 4.60E+3nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 4.20E+3nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 3.60E+3nMAssay Description:In vito concentration required to displace [3H]cyclofoxy (Kd = 0.8 nM and concentration is 1.3 nM) from mu and kappa2 receptor in rat brain membranes...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 9.90E+3nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.14E+4nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 7.80E+3nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 7.76E+4nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.31E+4nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.89E+4nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair
TargetRap guanine nucleotide exchange factor 3(Homo sapiens (Human))
University Hospital Jena
Curated by ChEMBL
University Hospital Jena
Curated by ChEMBL
Affinity DataIC50: 1.32E+4nMAssay Description:Antagonist activity at recombinant human full length EPAC1 assessed as inhibition of EPAC1-mediated Rap1B (1 to 167 residues)-BODIPY GDP nucleotide e...More data for this Ligand-Target Pair